Blog
Bridging the “Valley of Death” in Drug Development
Ginger Spitzer, the Executive Director for the Foundation for Sarcoidosis Research, will be a panelist at this year’s Drug Information Association’s Annual Conference. The DIA 2017 Annual Meeting is the largest, longest-running event in the life sciences...
CLEAR Trial: Phase II Investigation of Antimycobacterial Therapy of Progressive, Pulmonary Sarcoidosis
The main purpose of this study is to investigate the efficacy and safety of oral antimycobacterial therapy in patients with confirmed progressive pulmonary sarcoidosis. CLEAR is an acronym used to describe treatment with Combination Levofloxacin, Ethambutol,...